C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Name: C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
SKU: 3369
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 35 No. 1 Articles Tags: c-lindsay-devane, dosage-regimen-design, heidi-l-liston, medworks-media, pharmacokinetics, psychopharmacology, psychopharmacology-bulletin, second-dose-effect

Description

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD

Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas

Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais

Antipsychotic Induced Symptomatic Hyperprolactinemia

Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD

Related products

Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas

Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais

Antipsychotic Induced Symptomatic Hyperprolactinemia

Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason